The contractor shall perform assay development and validation to identify and evaluate efficacy of anti-HIV therapeutics and topical microbicides. Note: the validation process includes the…
Ended Awarded Last action
- Contract number
- 75N93019F00133
- Awardee
-
Southern Research Institute UEI CDZJAJJHJMH5
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $300,228
Award facts
- Contract value 100% obligated
- $300,228.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541712 Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Birmingham, AL 35205, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Close Out | $0 | |
| Other Administrative Action | $0 | |
| Original award | $300,228 |
About this award
The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $300,228.00 cost-plus-fixed-fee delivery order contract to Southern Research Institute, a corporate entity tax-exempt non-profit organization, to perform assay development and validation to identify and evaluate the efficacy of anti-HIV therapeutics and topical microbicides. This contract is part of the "In Vitro Testing Resource for HIV Therapeutics and Topical Microbicides" major program. Southern Research Institute has provided a range of services under past prime and sub-federal contracts and grants, including drug discovery and development, emerging infectious disease research, and assessing antimicrobial activity. This contract does not have a set-aside designation.
Description
The contractor shall perform assay development and validation to identify and evaluate efficacy of anti-HIV therapeutics and topical microbicides. Note: the validation process includes the determination and optimization of the accuracy, precision, RE
Quick answers
Who was awarded contract 75N93019F00133?
75N93019F00133 was awarded to Southern Research Institute by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on August 1, 2019.
How much is contract 75N93019F00133 worth?
The government has obligated $300,228 on 75N93019F00133.
Is contract 75N93019F00133 an order under another contract?
Yes. 75N93019F00133 is a delivery order under HHSN272201400010I, an indefinite delivery contract.
Was contract 75N93019F00133 competed?
The extent of competition for 75N93019F00133 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award